Investors and market participants can look forward to the unveiling of Insmed Incorporated (NASDAQ: INSM) third quarter financial results on Thursday 31st October 2024. This important update will be made available before market open.
the organization is poised to announce an estimated $1.21 loss per share for the quarter, as predicted by financial experts on Wall Street. Additionally, the firm is expected to reveal a total revenue of $93.01 million for this period.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share loss of $1.11. Notably, the company's total revenue reached an impressive $79.07 million during that specific period.
The experts on Wall Street have shared their predictions for how well the company will do this year. They think the total revenue will be around $356.56 million. They also believe the company will reach about loss of $5.25 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-1.94 | -9.0% | 90.34 M | +17.0% |
| Q1 2024 | $-1.06 | +9.4% | 75.50 M | +15.8% |
| Q4 2023 | $-1.28 | -5.8% | 83.69 M | +41.1% |
| Q3 2023 | $-1.11 | -1.8% | 79.07 M | +16.7% |
| Q2 2023 | $-1.78 | -122.5% | 77.23 M | +18.4% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 31st October 2024 at 08:00 AM eastern time, in a conference call with public.
Insmed Incorporated (INSM) shares traded as low as $70.23 and as high as $71.59 on a day volume of 1.05 million shares, closed Tuesday's regular trading session at $70.95, drop of 1.4 percent.
